SCHEMBL62191

SCHEMBL62191

CC(CCc1ccccc1)C(=O)N(c1ccco1)c1ncnc2[nH]cnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
USP2 O75604 1/20 0.33
LMNA P02545 3/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
GLA P06280 1/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
HPGD P15428 3/20 0.32
HTT P42858 2/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
CCR6 P51684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62190 0.71 ALDH1A1 (0.40) KMT2ATSHRALDH1A1GAALMNA
SCHEMBL8495356 0.70 CSF1R (0.36) KMT2ATSHRJAK2JAK1SMN1; SMN2
SCHEMBL3038559 0.66 CSF1R (0.39) KMT2AALDH1A1GAALMNAHTT
SCHEMBL9827990 0.65 NPC1 (0.47) TSHRALDH1A1GAAUSP2LMNA
SCHEMBL9222308 0.64 TSHR (0.51) TSHRALDH1A1GAAUSP2LMNA
SCHEMBL8045436 0.64 BRD4 (0.36) KMT2AALDH1A1JAK2JAK1HTT
SCHEMBL15950879 0.63 MAPT (0.51) KMT2ATSHRALDH1A1USP2LMNA
SCHEMBL2623135 0.63 KDM4E (0.39) KMT2ALMNAJAK2JAK1SMN1; SMN2
SCHEMBL8675770 0.62 NPSR1 (0.42) ALDH1A1LMNASMN1; SMN2HPGDHTT
SCHEMBL1898390 0.62 RAB9A (0.51) KMT2ATSHRALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926703-B1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP ASSETS BV (NL) 2013-01-09 EP claimed
US-20090258887-A1 Novel Carboxylic Acid Derivatives DSM ASSETS B.V. (NL) 2009-10-15 US claimed
EP-1926703-A1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP Assets B.V. (NL) 2008-06-04 EP claimed
WO-2007039059-A1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP ASSETS B.V. (NL) 2007-04-12 WO claimed
EP-1926703-B1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP ASSETS BV (NL) 2013-01-09 EP disclosed
US-8129562-B2 Carboxylic acid derivatives DSM IP ASSETS B.V. (NL) 2012-03-06 US disclosed
US-20110124726-A1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP ASSETS B.V. 2011-05-26 US disclosed
US-7906496-B2 Carboxylic acid derivatives DSM IP ASSETS B.V. (NL) 2011-03-15 US disclosed
US-20090258887-A1 Novel Carboxylic Acid Derivatives DSM ASSETS B.V. (NL) 2009-10-15 US disclosed
EP-1926703-A1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP Assets B.V. (NL) 2008-06-04 EP disclosed
WO-2007039059-A1 NOVEL CARBOXYLIC ACID DERIVATIVES DSM IP ASSETS B.V. (NL) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258887-A1 Novel Carboxylic Acid Derivatives AADAC, ALDH7A1, DDC KMT2A 1673/4885TSHR 2998/4885ALDH1A1 7/4885
US-20110124726-A1 NOVEL CARBOXYLIC ACID DERIVATIVES AADAC, ALDH7A1, ALDH18A1 KMT2A 1664/4885TSHR 2709/4885ALDH1A1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.